Norflex and Constipation aggravated for Women aged 40-49 (a phase IV clinical study of FDA data)
Summary:
Constipation aggravated is found for women aged 40-49 who take Norflex (orphenadrine citrate). This study is created by eHealthMe based on reports of 221 women aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Norflex when people have Constipation aggravated
- Top conditions
- Top co-used drugs
- Top other side effects
221 women aged 40-49 reported to have side effects when taking Norflex.
Among them, 15 people (6.79%) have Constipation aggravated
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,951 Norflex users. Check the latest studies of Norflex.
What is Constipation aggravated?
Constipation aggravated (constipation) is found to be associated with 4,156 drugs and 4,617 conditions by eHealthMe. Check the latest studies of Constipation aggravated.
Number of reports submitted per year:
Time on Norflex when people have Constipation aggravated *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Constipation aggravated
n/aHow people recovered from Constipation aggravated
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Neck Pain: 9 people, 60.00%
- Drowsiness: 3 people, 20.00%
- Pulmonary Congestion (congestion in the lungs): 1 person, 6.67%
- Impaired Gastric Emptying: 1 person, 6.67%
- Cough: 1 person, 6.67%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.67%
- Asthma: 1 person, 6.67%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Toradol: 13 people, 86.67%
- Tranxene: 12 people, 80.00%
- Zovirax: 1 person, 6.67%
- Fluconazole: 1 person, 6.67%
- Gaviscon: 1 person, 6.67%
- Glycolax: 1 person, 6.67%
- Heparin: 1 person, 6.67%
- Humulin R: 1 person, 6.67%
- Hydrocodone Bitartrate And Acetaminophen: 1 person, 6.67%
- Hydroxyzine: 1 person, 6.67%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Nausea (feeling of having an urge to vomit): 14 people, 93.33%
- Hypoaesthesia (reduced sense of touch or sensation): 14 people, 93.33%
- Injection Site Pain: 13 people, 86.67%
- Faecal Incontinence (a lack of control over passing stool): 13 people, 86.67%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 13 people, 86.67%
- Tinnitus (a ringing in the ears): 13 people, 86.67%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 80.00%
- Chest Pain: 12 people, 80.00%
- Difficulty In Walking: 12 people, 80.00%
- Dyspnea (difficult or laboured breathing): 11 people, 73.33%
* Approximation only. Some reports may have incomplete information.
Do you take Norflex and have Constipation aggravated?
- Check whether Constipation aggravated is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aspirin cause Torsade De Pointes? - now
- Drug interactions of Erlotinib Hydrochloride and Ventolin - now
- Drug interactions of Deferasirox and Acetylsalicylic Acid - 2 seconds ago
- Flonase and Stones - Kidney for Women aged 50-59 - 7 seconds ago
- Flonase and Renal Calculi for Women aged 50-59 - 7 seconds ago
- Flonase and Nephrolithiasis for Women aged 50-59 - 7 seconds ago
- Flonase and Kidney Stones for Women aged 50-59 - 8 seconds ago
- Fibrin D Dimer Increased and drugs of ingredients of tretinoin - 12 seconds ago
- Sulfasalazine and Neurontin drug interactions for women aged 40-49 - 13 seconds ago
- Could Serax cause Oedema? - 14 seconds ago